Bacteria and balance: how understanding the vaginal microbiome can help discover new drugs
The relationship between the human microbiome – that is, all the bacteria living in or on the human body –…
All articles by Darcy Jimenez
Darcy Jimenez
Darcy Jimenez is a healthcare reporter for Pharmaceutical Technology and Pharma Technology Focus magazine, covering drug research, development, production and regulation. She is particularly interested in stories about AI, antibiotic resistance, and global health equality.
-
-
US Pharmacopeia report finds high reliance on Indian manufacturers for APIs
The United States Pharmacopeia (USP) has launched a Medicine Supply Vulnerability Insights Series to identify and highlight weaknesses in the…
-
Two years of Covid-19: lessons the pandemic taught about delivering essential vaccines
In the face of a pandemic rapidly claiming lives worldwide, governments, organisations and pharma companies mobilised to provide Covid-19 vaccine…
-
New bill seeks to revamp FDA’s accelerated approvals programme
US House Energy and Commerce Committee chair Frank Pallone has introduced a new bill to ensure that drugs granted expedited…
-
Ukraine: Russian invasion could cause spike in Covid-19 cases
Since Russia began its invasion of Ukraine on 24 February, more than 400 civilians have been killed – but experts…
-
Profit for patients: can NFTs allow people to monetise their health data?
Whether you know what they are or not, chances are you’ve heard of non-fungible tokens, or NFTs. NFTs are digital…
-
Sanofi and GSK to seek approval for delayed Covid-19 vaccine
Sanofi and GlaxoSmithKline (GSK) plan to seek regulatory authorisation for their Covid-19 vaccine after reporting positive results from a late-stage…
-
Valneva receives up to £20m vaccine R&D funding in Scotland
The Scottish subsidiary of vaccine maker Valneva has been awarded up to £20m funding for the research and development of…
-
How vaccine science could help tackle antimicrobial resistance
In their ability to provide substantial protection against the worst effects of the novel coronavirus, vaccines are our ticket out…
-
New BIO report forecasts an uncertain future for the antibiotics sector
A new report examining the antibiotics landscape in the US has highlighted the need for public policy solutions as investments…